Back to Alzheimers Disease
NCT02006654
NCT02006654
Who may be able to join
Who might be able to join this trial:
- You have a caregiver who knows you well and can be relied upon to support you.
- You are living at home or in the community (not currently staying in a hospital).
- You have been diagnosed with Alzheimer's disease (AD).
- Your Alzheimer's disease is considered mild to moderate in severity.
- You are already taking a stable dose of a type of medication called an AChEI (a common type of Alzheimer's medication, such as donepezil or rivastigmine).
- If you are a woman, you either went through natural menopause at least 2 years ago, or you have had a surgical procedure meaning you cannot become pregnant.
- If you are a man, you agree to use effective contraception during the trial if your female partner could become pregnant, or you have already had a surgical procedure meaning you cannot father children.
Who may not be able to join:
- You have signs of another significant brain or nervous system condition besides Alzheimer's disease.
- You have been diagnosed with certain other mental health conditions (beyond Alzheimer's disease) as defined by a standard medical classification system (confirm with trial site).
- You have evidence of another serious significant medical illness or condition (confirm with trial site for details).
- It is expected that your current Alzheimer's medication (AChEI) may be stopped or interrupted at any point during the trial.
- You are currently taking a medication called memantine, or you have taken it within the last 2 months.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Trial details
Status
Completed
Phase
Phase 3
Sponsor
H. Lundbeck A/S
Registry
clinicaltrials_gov
Start date
1 March 2014
Est. completion
1 January 2017
Where this trial is recruiting
🇦🇺 Australia
🇧🇷 Brazil
🇨🇿 Czechia
🇩🇪 Germany
🇮🇱 Israel
🇲🇽 Mexico
🇷🇸 Serbia
🇸🇬 Singapore
🇸🇰 Slovakia
🇰🇷 South Korea
🇪🇸 Spain
🇨🇭 Switzerland
Turkey (Türkiye)
🇬🇧 United Kingdom
🇺🇸 United States
7 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Change in Cognition
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.